Cell Therapy Clinical Trials Report

Industry perspectives on the current cell therapy clinical trial landscape

The PPD clinical research business of Thermo Fisher Scientific responded to the increasing growth and demand for regenerative medicines by surveying executives engaged in cell therapy clinical trials at pharmaceutical and biopharmaceutical companies. This report explores their positions on aspects of cell therapy trials, including:

• the current landscape
• the biggest challenges facing their organizations
• satisfaction with solutions offered by contract research organizations (CROs)